Business Context and Reporting Period
Company: MEDICINOVA INC
Filing Type: Form 8-K (Current Report)
Date of Report: September 16, 2016
Event: Entry into a Material Definitive Agreement (Amendment No. 1 to At-the-Market Issuance Sales Agreement).
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the amendment of a securities sales agreement.
- Remaining Shares Available for Sale: $29,967,000 worth of common stock.
- Original Registration Expiry: December 3, 2015 (expired).
- New Shelf Registration Expiry: August 29, 2019.
Material Changes Versus Prior Period
The Company amended its Original Sales Agreement (dated May 22, 2015) with MLV & Co. LLC to include FBR Capital Markets & Co. as an additional sales agent. Additionally, the Company moved the remaining registered shares from an expired Form S-3 registration statement (File No. 333-185022) to a new outstanding Form S-3 shelf registration statement (File No. 333-208274).
Guidance, Outlook, and Risks
Management Commentary: The filing states that no additional shares are being registered for sale; only the remaining shares previously registered are being transferred to the new shelf registration statement to extend the sales window.
Risks/Contingencies: The filing includes a standard disclaimer that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful prior to registration or qualification.
Important Facts for Investor Verification
- Verify the terms of the new sales agreement with FBR Capital Markets & Co. as detailed in Exhibit 10.1.
- Confirm the status of the Form S-3 shelf registration statement (File No. 333-208274) and its validity through August 29, 2019.
- Note that the total value of shares available for sale under the amended agreement is $29,967,000.
- Review the legal opinion filed as Exhibit 5.1 regarding the legality of the shares to be issued.